Clinical Trial Update: Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating dextroamphetamine as an adjunct for cocaine- and opioid-dependent patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine-related Disorders
• Opioid-related Disorders

Drugs mentioned

• Dextroamphetamine (Dextroamphetamine)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-Related Disorders, Opioid-Related Disorders | Phase 2 | Status: COMPLETED